LONDON/COPENHAGEN, Dec 23 (Reuters) - Novo Nordisk ‌secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a shot at reclaiming ground lost to rival Eli Lilly. Booming ...

A major analysis reveals which GLP-1 drugs deliver the best results for glucose control, weight loss, and side effect profiles, offering new clarity for diabetes care decisions. Study: Efficacy and ...

Last week, Tara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance. A major change to her prescription benefits meant the medication she was ...

LONDON/COPENHAGEN (Reuters) -Danish drugmaker Novo Nordisk is facing a major challenge to its blockbuster weight-loss drug Wegovy. Booming sales of Wegovy powered the firm to become Europe's most ...